STOK·86150R107·US·equity·Healthcare - Biotechnology-13D/G
STOK (STOKE THERAPEUTICS INC) is held by 113 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($183.1M), BlackRock, Inc. ($175.4M), FMR LLC ($175.3M). Net institutional sentiment: Mixed.
See how STOK's score breaks down across 4 SEC sources
Showing 1-20 of 123
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer